ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 6969

$1.75M Total Retail Price of All Prescriptions

Rank: 46 out of 6969

638 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 23,942 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,149 1,107 1 4
LOSARTAN POTASSIUM 834 815 2 12
DONEPEZIL HCL 765 764 3 32
DIOVAN 715 714 4 26
SIMVASTATIN 682 668 5 1
LIDODERM 641 613 6 75
ATENOLOL 625 606 7 9
ALBUTEROL SULFATE 600 587 8 123
EVISTA 578 569 9 118
NEXIUM 507 469 10 52
METFORMIN HCL 484 449 11 7
OMEPRAZOLE 479 471 12 6
BETAMETHASONE DIPROPIONATE 428 395 10 13 250
GLIPIZIDE 419 407 14 21
ATORVASTATIN CALCIUM 399 383 15 11
NAPHAZOLINE HCL 377 369 16 245
JANUVIA 367 364 17 41
VOLTAREN 364 349 18 105
GABAPENTIN 359 344 19 17
SINGULAIR 350 348 20 84
AMOXICILLIN 336 330 21 99
AZITHROMYCIN 324 310 22 42
AVODART 320 320 23 108
NASONEX 293 285 24 144
ALENDRONATE SODIUM 280 268 25 14
PATANOL 261 261 26 142
TERAZOSIN HCL 247 247 27 49
CELEBREX 245 233 28 67
TRIAMCINOLONE ACETONIDE 244 240 29 55
DIOVAN HCT 244 244 29 57
CLOPIDOGREL 240 240 31 48
MONTELUKAST SODIUM 235 230 32 151
CRESTOR 230 210 33 39
MELOXICAM 226 226 34 36
TAMSULOSIN HCL 221 221 35 23
MUPIROCIN 216 197 36 291
CIPROFLOXACIN HCL 207 202 37 64
PLAVIX 194 193 38 68
EXELON 193 193 39 157
CARVEDILOL 191 191 40 25
FLUTICASONE PROPIONATE 191 183 40 24
LOVAZA 177 163 42 77
LEVOTHYROXINE SODIUM 176 176 43 5
METOPROLOL SUCCINATE 168 164 44 22
PROAIR HFA 165 151 45 33
GEMFIBROZIL 155 147 46 85
TRAMADOL HCL 152 150 47 27
NEOMYCIN-POLYMYXIN-DEXAMETH 151 149 48 416
LOSARTAN-HYDROCHLOROTHIAZIDE 150 149 49 53
PROCTOZONE-HC 140 139 50 293
NIFEDIPINE ER 135 135 51 95
CEPHALEXIN 134 126 52 96
FLUOCINONIDE 127 118 53 134
PAROXETINE HCL 126 123 54 65
PATADAY 125 124 55 213
CLONIDINE HCL 114 114 56 59
TRIAMTERENE-HCTZ 112 109 57 58
PREDNISONE 111 108 58 70
ISOSORBIDE MONONITRATE ER 109 109 59 81
CREON 109 108 59 147
DILTIAZEM 24HR CD 103 103 61 191
GLYBURIDE-METFORMIN HCL 101 101 R 62 92
BENICAR 91 84 63 107
PRAVASTATIN SODIUM 89 88 64 19
NAMENDA 86 86 65 51
ZOLPIDEM TARTRATE 86 86 65 16
ZETIA 84 83 67 98
PANTOPRAZOLE SODIUM 79 79 68 31
ADVAIR DISKUS 77 72 69 45
ALLOPURINOL 76 72 70 35
DEXILANT 75 75 71 110
TRAZODONE HCL 71 69 72 47
NAPROXEN 70 68 73 62
DESOXIMETASONE 70 70 73 394
AMLODIPINE BESYLATE-BENAZEPRIL 69 69 75 91
LANSOPRAZOLE 67 67 76 171
LIPITOR 67 65 76 89
ISOSORBIDE DINITRATE 65 65 78 231
CLOBETASOL PROPIONATE 63 63 79 230
DIGOXIN 61 61 80 71
IBANDRONATE SODIUM 60 58 81 178
PROPRANOLOL HCL 60 57 81 153
VYTORIN 59 58 83 148
MIRTAZAPINE 58 38 84 76
ECONAZOLE NITRATE 58 48 84 290
NEOMYCIN-POLYMYXIN-HYDROCORT 57 55 86 407
MECLIZINE HCL 55 51 87 100
RANITIDINE HCL 54 51 88 46
FUROSEMIDE 53 53 89 10
PROCTOSOL-HC 52 51 90 364
ACTONEL 51 45 91 115
RAPAFLO 50 50 92 347
BENAZEPRIL HCL 50 49 92 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.